Don't Even Think About Viatris Before Reading This Report!

Large-cap Health Care company Viatris has logged a -2.1% change today on a trading volume of 4,195,988. The average volume for the stock is 9,527,865.

Viatris Inc. operates as a healthcare company worldwide. Based in Canonsburg, United States the company has 38,000 full time employees and a market cap of $11,396,780,032. Viatris currently offers its equity investors a dividend that yields 4.9% per year.

The company is now trading -34.22% away from its average analyst target price of $14.45 per share. The 11 analysts following the stock have set target prices ranging from $10.0 to $35.0, and on average give Viatris a rating of buy.

Over the last year, VTRS shares have gone down by -16.4%, which represents a difference of -23.0% when compared to the S&P 500. The stock's 52 week high is $12.4 per share and its 52 week low is $8.42. Based on Viatris's 4.2% compound average gross margin growth rate over the last 4 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 16,262,700 9,765,700 39.95 28.17
2021-12-31 17,886,300 12,310,800 31.17 -1.92
2020-12-31 11,946,000 8,149,300 31.78 -6.23
2019-12-31 11,500,500 7,602,900 33.89 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS